Resigratinib
Resigratinib (KIN-3248) is a potent, kinome selective, irreversible, orally bioavailable, small-molecule inhibitor of pan-FGFR. It exhibits dose-dependent tumor inhibition in FGFR driven cholangiocarcinoma, gastric, and bladder cancer xenograft models.
| Trivial name | KIN-3248 |
| Catalog Number | E1814 |
| CAS# | 2750709-91-0 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/resigratinib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E1814-Resigratinib-chemical-structure.png |